A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010)

Clinical trial NCT01021748 · COMPLETED

Trial details

NCT number: NCT01021748
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors

Start date: 2009-11-23
Primary completion: 2012-11-26
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.